Effect of Helicobacter pylori eradication therapy on risk of hospitalization for a major ulcer event. (scientific article published in March 2011)

Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong

Q30482912

Causes underlying the birth-cohort phenomenon of peptic ulcer: analysis of mortality data 1911-2000, England and Wales

Q31041312

Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis

Q35872061

Current management of peptic ulcer bleeding

Q36362419

The health economics of Helicobacter pylori infection

Q36768715

Helicobacter pylori infection in Ontario: prevalence and risk factors

Q37134187

Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland.

Q39887184

Current features of peptic ulcer disease in Finland: incidence of surgery, hospital admissions and mortality for the disease during the past twenty-five years

Q42041309

Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan

Q43775988

Time, change and peptic ulcer disease in Rotherham, UK.

Q44705489

Eradicating Helicobacter pylori in peptic ulcer disease reduces medical costs in the community

Q46105426

Relationship between the birth cohort pattern of Helicobacter pylori infection and the epidemiology of duodenal ulcer.

Q51709200

Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002

Q57274534

Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study

Q58236244

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

Helicobacter pylori

Q180556

hospitalization